Daniel Bradbury - Profile and Investment Details

Investor Profile

Daniel Bradbury is a Venture Capital, Founder, Angel/Individual, Investor based in San Diego, California, United States with a diverse investment portfolio that includes companies such as Amylin Pharmaceuticals, Tavo Biotherapeutics, Cerexa, Minutia , NeuroVia, Alume Biosciences, PhRMA, Thesan PharmaceuticalsNovacea, Freedom Meditech Inc., Equillium, Inc., Syngene International Limited, BioMed Realty, Illumina, SmithKline Beecham, Microdermis, Biocom California, Corcept Therapeutics, Penninsula Pharmaceuticals, Geron, Amylin Europe Ltd, . Over time, Daniel Bradbury has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Daniel Bradbury is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Biotechnology, Pharmaceuticals may find it worthwhile to explore potential connections with Daniel Bradbury, as their portfolio suggests a familiarity and interest in this area.

Understanding Daniel Bradbury’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.